Education
About Us
Working with TipRanks
Follow Us
Diagonal Bio AB (DE:9F1)
:9F1
9F1 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.02 - €0.03
Previous CloseN/A
Volume0.00
Average Volume (3M)N/A
Market Cap
€984.03K
Enterprise Value-€3.14M
Total Cash (Recent Filing)€1.73M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta7.23
Next Earnings
Aug 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,214,965,300
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.33
Price to Sales (P/S)0.00
P/FCF Ratio-0.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
9F1 FAQ
What was Diagonal Bio AB’s price range in the past 12 months?
Diagonal Bio AB lowest stock price was €0.02 and its highest was €0.03 in the past 12 months.
What is Diagonal Bio AB’s market cap?
Diagonal Bio AB’s market cap is €984.03K.
When is Diagonal Bio AB’s upcoming earnings report date?
Diagonal Bio AB’s upcoming earnings report date is Aug 22, 2025 which is in 54 days.
How were Diagonal Bio AB’s earnings last quarter?
Diagonal Bio AB released its earnings results on May 14, 2025. The company reported >-€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-€0.001.
Is Diagonal Bio AB overvalued?
According to Wall Street analysts Diagonal Bio AB’s price is currently Overvalued.
Does Diagonal Bio AB pay dividends?
Diagonal Bio AB does not currently pay dividends.
What is Diagonal Bio AB’s EPS estimate?
Diagonal Bio AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Diagonal Bio AB have?
Diagonal Bio AB has 1,214,965,300 shares outstanding.
What happened to Diagonal Bio AB’s price movement after its last earnings report?
Diagonal Bio AB reported an EPS of >-€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Diagonal Bio AB?
Currently, no hedge funds are holding shares in DE:9F1
Company Description
Diagonal Bio AB
Diagonal Bio AB is developing a diagnostic platform for ultra-rapid, parallel, accurate and cost-efficient detection of any kind of pathogen - Panviral.
2cureX AB
―
LIDDS AB
―
Lipigon Pharmaceuticals AB
―
―
QuiaPEG Pharmaceuticals Holding AB
―